Pure Global

Combination Effect of Optical Defocus and Low Dose Atropine in Myopia Control - Trial NCT06358755

Access comprehensive clinical trial information for NCT06358755 through Pure Global AI's free database. This Phase 2 trial is sponsored by The Hong Kong Polytechnic University and is currently Not yet recruiting. The study focuses on Myopia. Target enrollment is 112 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
NCT06358755
Phase 2
Not yet recruiting
Device Trial
device
Trial Details
ClinicalTrials.gov โ€ข NCT06358755
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Combination Effect of Optical Defocus and Low Dose Atropine in Myopia Control
Combination Effect of Optical Defocus and Low Dose Atropine in Myopia Control - a Randomized Clinical Trial

Study Focus

Myopia

Defocus Incorporated Multiple Segments lenses

Interventional

device

Sponsor & Location

The Hong Kong Polytechnic University

Hong Kong, China

Timeline & Enrollment

Phase 2

May 01, 2024

Oct 31, 2026

112 participants

Primary Outcome

Changes in cycloplegic refraction,Changes in axial length

Summary

The purpose of the study is to investigate the combination effect of optical defocus and low
 dose atropine on myopia control in schoolchildren.

ICD-10 Classifications

Myopia
Degenerative myopia
Amblyopia ex anopsia
Ocular myiasis
Myiasis

Data Source

ClinicalTrials.gov

NCT06358755

Device Trial